The RBD Of The Spike Protein Of SARS-Group Coronaviruses Is A Highly Specific Target Of SARS-CoV-2 Antibodies But Not Other Pathogenic Human and Animal Coronavirus Antibodies

A new Severe Acute Respiratory Syndrome Coronavirus variant (SARS-CoV-2) that first emerged in late 2019 is responsible for a pandemic of severe respiratory illness. People infected with this highly contagious virus present with clinically inapparent, mild or severe disease. Currently, the presence...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:medRxiv
Auteurs principaux: Premkumar, Lakshmanane, Segovia-Chumbez, Bruno, Jadi, Ramesh, Martinez, David R., Raut, Rajendra, Markmann, Alena, Cornaby, Caleb, Bartelt, Luther, Weiss, Susan, Park, Yara, Edwards, Caitlin E., Weimer, Eric, Scherer, Erin M., Roupael, Nadine, Edupuganti, Sri, Weiskopf, Daniela, Tse, Longping V., Hou, Yixuan J., Margolis, David, Sette, Alessandro, Collins, Matthew H., Schmitz, John, Baric, Ralph S., de Silva, Aravinda M.
Format: Artigo
Langue:Inglês
Publié: Cold Spring Harbor Laboratory 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7274253/
https://ncbi.nlm.nih.gov/pubmed/32511572
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.05.06.20093377
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires